iCoreConnect Inc. (NASDAQ:ICCT – Get Free Report) was the recipient of a large decrease in short interest during the month of February. As of February 15th, there was short interest totalling 46,300 shares, a decrease of 37.3% from the January 31st total of 73,900 shares. Currently, 3.3% of the shares of the stock are short sold. Based on an average daily trading volume, of 620,500 shares, the short-interest ratio is presently 0.1 days.
Institutional Investors Weigh In On iCoreConnect
An institutional investor recently bought a new position in iCoreConnect stock. Magnus Financial Group LLC acquired a new stake in shares of iCoreConnect Inc. (NASDAQ:ICCT – Free Report) during the 4th quarter, according to its most recent filing with the SEC. The institutional investor acquired 25,010 shares of the company’s stock, valued at approximately $63,000. Magnus Financial Group LLC owned about 2.05% of iCoreConnect at the end of the most recent quarter. 13.42% of the stock is owned by hedge funds and other institutional investors.
iCoreConnect Stock Performance
iCoreConnect stock opened at $0.68 on Tuesday. iCoreConnect has a fifty-two week low of $0.64 and a fifty-two week high of $35.80. The firm’s fifty day moving average price is $2.27 and its 200-day moving average price is $4.98. The stock has a market cap of $1.40 million, a P/E ratio of -0.01 and a beta of 0.87. The company has a debt-to-equity ratio of 7.93, a quick ratio of 0.11 and a current ratio of 0.11.
iCoreConnect Company Profile
iCoreConnect Inc, a cloud-based software and technology company, provides Health Insurance Portability and Accountability Act (HIPAA) compliant cloud-based software as a service (SaaS) in the United States. The company’s products include iCoreRx, a HIPAA compliant electronic prescription software; iCorePDMP, a solution that checks the patient’s Prescription Drug Monitoring Program (PDMP) history before prescribing controlled substances; iCoreVerify and iCoreVerify+, a HIPAA compliant SaaS solution that automatically retrieves a patients insurance eligibility breakdown to verify their benefits in advance of their appointment and on-demand; iCoreHuddle and iCoreHuddle+, a tool to instantly reveal the revenue potential of each patient; and iCoreCodeGenius, a medical coding reference SaaS solution.
Featured Stories
- Five stocks we like better than iCoreConnect
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Intuitive Machines: March 6 Is a Pivotal Day for Lunar Economy
- 3 Dividend Kings To Consider
- Rocket Lab’s Plunge: Buy the Dip or Watch from the Sidelines?
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Mediterranean Growth Monster: CAVA Keeps Surging—Buy the Dip?
Receive News & Ratings for iCoreConnect Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iCoreConnect and related companies with MarketBeat.com's FREE daily email newsletter.